The Cymbalta Pregnancy Registry



Status:Recruiting
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:18 - Any
Updated:1/9/2019
Start Date:July 2009
End Date:December 2020
Contact:The Cymbalta Pregnancy Registry Call Center
Email:pregnancyregistries@incresearch.com
Phone:1-866-814-6975

Use our guide to learn which trials are right for you!

The Cymbalta Pregnancy Registry is a U.S. based Registry designed to monitor women who are
exposed to Cymbalta (duloxetine) during pregnancy. This is an observational,
exposure-registration and follow-up registry.


Inclusion Criteria:

- Sufficient evidence (e.g., date or gestational age) to confirm that Cymbalta exposure
occurred during pregnancy

- Sufficient data to establish in which trimester of pregnancy the exposure to Cymbalta
first occurred (i.e., first, second or third trimester)

- Sufficient information to determine whether the pregnancy is prospectively or
retrospectively registered (i.e., whether the outcome of pregnancy was known at the
time of first contact with the Registry)

- Date the pregnancy exposure is reported to the Registry

- Source of the report (Health Care Professional or pregnant patient)

- Full contact information for the reporter and Health Care Professional willing and
able to provide accurate pregnancy-related information (name, address, phone number,
etc.)

Exclusion Criteria:

- Reported cases that do not meet the minimum criteria for Registry enrollment are
deemed ineligible.
We found this trial at
1
site
Wilmington, North Carolina 28405
Principal Investigator: Vikki Brown
Phone: 910-509-4700
?
mi
from
Wilmington, NC
Click here to add this to my saved trials